Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C.

CONCLUSION: HCV infections remain a major public health concern among patients in the District of Columbia. This study identified fibrosis stage and prior insurance denial as primary barriers to access of HCV treatment. While there are many points in the hepatitis cascade of care in which patients can lose access to or fail treatment completion, the primary point of intervention in our patient population appears to be during the initiation of treatment and insurance prior authorization process. PMID: 32868101 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32868101?dopt=Abstract

Source: Journal of the National Medical Association - September 3, 2020 Category: General Medicine Tags: J Natl Med Assoc Source Type: research